Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q2 FY26ended Jun 30, 2026 | Jul 22, 2026 | $4.25 | +37.1% | $707.33M | +17.2% | $3.98 |
| Q1 FY26ended Mar 31, 2026 | Apr 22, 2026 | $4.28 | +16.6% | $706.60M | +26.5% | $3.92 |
| Q4 FY25ended Dec 31, 2025 | — | $4.67 | +27.2% | $708.45M | +32.0% | — |
| Q3 FY25ended Sep 30, 2025 | — | $3.86 | +28.2% | $659.90M | +23.7% | — |
| Q2 FY25ended Jun 30, 2025 | — | $3.10 | +12.7% | $603.31M | +14.2% | — |
| Q1 FY25ended Mar 31, 2025 | — | $3.67 | +14.7% | $558.57M | +9.3% | — |
| Q4 FY24ended Dec 31, 2024 | — | $3.67 | +49.2% | $536.59M | +7.7% | — |
| Q3 FY24ended Sep 30, 2024 | — | $3.01 | +35.6% | $533.32M |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe Medpace shares, not any token. As of Jul 22, 2026, from Massive's standardised financials and the earnings calendar.
| +8.3% |
| — |
| Q2 FY24ended Jun 30, 2024 | — | $2.75 | — | $528.10M | — | — |
| Q1 FY24ended Mar 31, 2024 | — | $3.20 | — | $511.04M | — | — |
| Q4 FY23ended Dec 31, 2023 | — | $2.46 | — | $498.40M | — | — |
| Q3 FY23ended Sep 30, 2023 | — | $2.22 | — | $492.50M | — | — |